Nutriband Inc. Stock Price

NasdaqCM:NTRB Community·US$72.5m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
3 Fair Values set on narratives written by author

Create a narrative

NTRB Share Price Performance

US$6.03

1.16 (23.82%)

US$6.03

1.16 (23.82%)

US$6.03

Sun, 9 Nov 25

Share PriceUS$6.03

NTRB Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks

0 Rewards

View Full Analysis

Nutriband Inc. Key Details

Last Reported Earnings

Jul 31, 2025

Next Reporting Earnings

n/a

: -2.67
: 34.36%
: -1,244.44%
: 2.1%

View Full Analysis

About NTRB

Founded: 2016
Employees: n/a
CEO: Gareth Sheridan
WebsiteView website: www.nutriband.com

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company’s lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company has commercial development and clinical supply agreement with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.